Chiron Accepts Higher Bid From Novartis.

Reports on the decision of Chiron Corp. to accept the offer of Novartis Corp. to acquire some of Chiron's stock shares in the U.S. Views of Novartis CEO, Daniel Vasella regarding his plan for Chiron; Reasons of Novartis on the acquisition of the shares of Chiron; Business forecast of Novartis for the global vaccine market in the next few years.